Zobrazeno 1 - 10
of 313
pro vyhledávání: '"real-world evidence (RWE)"'
Autor:
Catherine Y. Lau, Nigel S. B. Rawson
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5599-5607 (2024)
Canada is known to have a complex pathway for new drug approval and reimbursement, resulting in delayed access for patients with serious and life-threatening diseases, such as cancer. Several recent publications from key stakeholders, including patie
Externí odkaz:
https://doaj.org/article/f93c407c05234ae4a935cd5827261ee2
Publikováno v:
Фармакоэкономика, Vol 16, Iss 4, Pp 671-680 (2024)
The article is devoted to the study of regulatory approaches to the sphere of real-world data (RWD) and real world evidence (RWE) in the countries of the Asia-Pacific Region (China, South Korea, Japan, Taiwan, etc.) and examples of their practical ap
Externí odkaz:
https://doaj.org/article/853acf45b342447abd3db6c338f51c2d
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 4, Iss , Pp 100056- (2024)
Background: Data on patient outcomes with human epidermal growth factor receptor 2 (HER2)-directed therapy after detection of ERBB2 amplification (ERBB2 amp) by circulating tumor DNA (ctDNA) are lacking in advanced gastroesophageal adenocarcinoma (aG
Externí odkaz:
https://doaj.org/article/a3debff108c0469d828a64b8ea51189a
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 535-547 (2023)
Stephen S Johnston,1 Mosadoluwa Afolabi,1 Pranjal Tewari,2 Walter Danker3 1MedTech Epidemiology and Real-World Data Sciences, Johnson and Johnson, New Brunswick, NJ, USA; 2Mu Sigma, Bangalore, India; 3Franchise Health Economics and Market Access, Eth
Externí odkaz:
https://doaj.org/article/de618b88d4bb489aab4a9a658e4e0c10
Publikováno v:
Frontiers in Drug Safety and Regulation, Vol 4 (2024)
Externí odkaz:
https://doaj.org/article/297c7af5652c4ef8a289810ed69c2411
Autor:
Catherine Y. Lau
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 27 (2024)
Externí odkaz:
https://doaj.org/article/90fd1762552a4e4192eeba187891e1be
Autor:
Soowoo Back, Bethany Knox, Ciara Coakley, Nicolas Deltour, Emmanuelle Jacquot, Hanaya Raad, Elizabeth M. Garry
Publikováno v:
Vaccines, Vol 12, Iss 6, p 651 (2024)
The mpox 2022 outbreak was declared a public health emergency in July 2022. In August 2022, the MVA–BN vaccine received emergency use authorization in the United States (US) to target at-risk groups. This study (EUPAS104386) used HealthVerity’s a
Externí odkaz:
https://doaj.org/article/e01038aed0cb4804881a74f83c7e6304
Autor:
Tim Spelman, Melinda Magyari, Helmut Butzkueven, Anneke Van Der Walt, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Dana Horáková, Jirí Drahota, Fabio Pellegrini, Robert Hyde, Pierre Duquette, Jeannette Lechner-Scott, Seyed Aidin Sajedi, Patrice Lalive, Vahid Shaygannejad, Serkan Ozakbas, Sara Eichau, Raed Alroughani, Murat Terzi, Marc Girard, Tomas Kalincik, Francois Grand'Maison, Olga Skibina, Samia J. Khoury, Bassem Yamout, Maria Jose Sa, Oliver Gerlach, Yolanda Blanco, Rana Karabudak, Celia Oreja-Guevara, Ayse Altintas, Stella Hughes, Pamela McCombe, Radek Ampapa, Koen de Gans, Chris McGuigan, Aysun Soysal, Julie Prevost, Nevin John, Jihad Inshasi, Leszek Stawiarz, Ali Manouchehrinia, Lars Forsberg, Finn Sellebjerg, Anna Glaser, Luigi Pontieri, Hanna Joensen, Peter Vestergaard Rasmussen, Tobias Sejbaek, Mai Bang Poulsen, Jeppe Romme Christensen, Matthias Kant, Morten Stilund, Henrik Mathiesen, Jan Hillert, The Big MS Data Network: a collaboration of the Czech MS Registry, the Danish MS Registry, Italian MS Registry, Swedish MS Registry, MSBase Study Group, and OFSEP
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundTreatment switching is a common challenge and opportunity in real-world clinical practice. Increasing diversity in disease-modifying treatments (DMTs) has generated interest in the identification of reliable and robust predictors of treatme
Externí odkaz:
https://doaj.org/article/3d52ca1fdc794fa48cba7a9cc328885d
Autor:
Kuang-Hua Huang, Ya-Lan Chang, Chiachi Bonnie Lee, Shuo-Yan Gau, Tung-Han Tsai, Ning-Jen Chung, Chien-Ying Lee
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Recent studies have demonstrated that patients with type 2 diabetes mellitus (T2DM) who receive metformin have a decreased risk of developing age-related macular degeneration (AMD). However, other studies have also suggested that metformi
Externí odkaz:
https://doaj.org/article/525576149ae2497889d44ecbda428864
Autor:
Kristoffer Larsen, Ryan N. Walton, Mohamed Elsayed, Andrey Ipatov, Faye Townsend-Holyoake, Sebastian F. A. Axelsson, Nacho Quinones, Rudiger Papsch, Jennifer Givens, Alexander Bedenkov, Michael Seewald
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
The past decade has seen the increasing influence and relevance of real-world data (RWD) and real-world evidence (RWE) in healthcare decision making. The value added by RWD/RWE has prompted the pharmaceutical industry to develop high performing syste
Externí odkaz:
https://doaj.org/article/d36fe1f2c8674c31ab60f6d323dab5af